Last Name


Mary Jo Fidler to Oropharyngeal Neoplasms

This is a "connection" page, showing publications Mary Jo Fidler has written about Oropharyngeal Neoplasms.

Connection Strength
  1. Raman A, Sen N, Ritz E, Fidler MJ, Revenaugh P, Stenson K, Al-Khudari S. Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer. Am J Otolaryngol. 2019 Sep - Oct; 40(5):626-630.
    View in: PubMed
    Score: 0.193
  2. Sher DJ, Rusthoven CG, Khan SA, Fidler MJ, Zhu H, Koshy M. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma. Cancer. 2017 01 01; 123(2):273-282.
    View in: PubMed
    Score: 0.160
  3. Sher DJ, Schwartz DL, Nedzi L, Khan S, Hughes R, Fidler MJ, Koshy M. Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis. Oral Oncol. 2016 Mar; 54:58-67.
    View in: PubMed
    Score: 0.153
  4. Sher DJ, Fidler MJ, Tishler RB, Stenson K, al-Khudari S. Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):512-22.
    View in: PubMed
    Score: 0.151
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.